Virginiamycin S1

DB04805ExperimentalSmall molecule

One of the components of virginiamycin, a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. Loidensis, s. Mitakaensis, s. Pristina-spiralis, s. Ostreogriseus, and others. It is used to treat infections... It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.

Formula / weight: C₄₃H₄₉N₇O₁₀ · 823.904 g/mol (avg)
Also known as: Staphylomycin S · Staphylomycin S1 · Virginiamycin factor S · Virginiamycin factor S1
Code names: Antibiotic 1754Z3B · NSC-177858

Resolves to

Compound

UNIIJ91D5GN5ATCAS23152-29-6ChEMBLCHEMBL1236684ChEBI46416PubChem5388936KEGGC11269

Structure

InChIKeyFEPMHVLSLDOMQC-IYPFLVAKSA-NSMILES

[H][C@@]12CCCN1C(=O)[C@@H](CC)NC(=O)[C@@H](NC(=O)C1=NC=CC=C1O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@]1([H])CC(=O)CCN1C(=O)[C@]([H])(CC1=CC=CC=C1)N(C)C2=O)C1=CC=CC=C1

Targets

P61927RPL37

What you can answer from here — as of June 12, 2020

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Virginiamycin S1, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account